Chris Sandburg
Recent Articles by Chris Sandburg
- Handicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout
- CytoDyn (OTCMKTS:CYDY) May Make the White House Podium
- Wading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
- Fintech Rollup Xalles (OTCMKTS: XALL) Shocks Street with Acquisition that Doubles Revenues
- CytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval
- FingerMotion (OTCMKTS: FNGR) Enters Big Data Space Solving Huge Inefficiencies in InsureTech Like IPO Darling Lemonade (NASDAQ: LMND)
- CytoDyn (OTCMKTS: CYDY) Bolts Higher On Mexican Approval Chatter
- Job Market Stocks Poised to Soar Once the Back to Work Order is Cleared
- Gilead (NASDAQ: GILD) Shares Jump On Trial Results and Fauci Despite 9.3% Mortality Rate After 14 Days
- UK Prime Minister Boris Johnson Linkage to CytoDyn (OTCMKTS: CYDY) Evolving